Blog
RSS FeedPosted by Michael Wonder on 18 Feb 2017
The refusal of Medicare to fund a $60 blood test means cancer patients miss out on treatment
19 February 2017 - Mother of two Lisa Briggs and thousands of other lung cancer patients battling the nation’s deadliest ...
Posted by Michael Wonder on 07 Feb 2017
Updated PBAC outcomes for November 2016
7 February 2017 - Subsequent to the deferral at the November 2016 PBAC meeting, the PBAC recommended the PBS listing of ...
Posted by Michael Wonder on 06 Feb 2017
Funding cuts threat for radiation patients
6 February 2017 - Radiologists have warned that a $23.7 million cut to federal support for cancer-fighting equipment will undermine ...
Posted by Michael Wonder on 01 Feb 2017
Advanced ovarian cancer treatment placed on the PBS, a move praised by doctors and patients
1 January 2017 - Women with advanced ovarian cancer can now pay significantly less for a groundbreaking drug, in a ...
Posted by Michael Wonder on 31 Jan 2017
Patients battling deadly ovarian, lung cancer to have affordable access to new drugs
31 January 2017 - Sick patients battling deadly cancers will have affordable access to new drugs which usually cost more ...
Posted by Michael Wonder on 16 Jan 2017
‘Precision medicine’ promises new hope for cancer sufferers
17 January 2017 - A shift from mass to personalised medicine promises new hope for cancer sufferers and health authorities, ...
Posted by Michael Wonder on 05 Dec 2016
Company brings unapproved life saving drugs to Australia. But is it medicine for the rich?
5 December 2016 - When the cancer in Karen Cowley's breast spread to her spine and brain, and her current ...
Posted by Michael Wonder on 18 Oct 2016
Rare cancer patients push for better medication access, say current PBS framework is unfair
18 October 2016 - Patients with rare cancers have ramped up calls on the Federal Government to change regulations around ...
Posted by Michael Wonder on 16 Oct 2016
Rare cancer sufferers face long waits, high costs for treatment
16 October 2016 - Lillian Leigh was taking in the view from the train on her way home from work ...
Posted by Michael Wonder on 04 Oct 2016
Costs and concerns in cancer care
5 October 2016 - Some recently developed anticancer drugs appear to be a major advance. ...
Posted by Michael Wonder on 02 Oct 2016
Schedule of Pharmaceutical Benefits - 1 October 2016 update
1 October 2016 - The 1 October 2016 issue of the Schedule of Pharmaceutical Benefits sees a number of new ...
Posted by Michael Wonder on 01 Oct 2016
Breast cancer drug tamoxifen listed on Pharmaceutical Benefits Scheme
1 October 2016 - More Australian women will have access to a preventative breast cancer medicine that has been listed on ...
Posted by Michael Wonder on 30 Sep 2016
Recommendations made by the PBAC - August 2016
30 September 2016 - The outcomes from the August 2016 PBAC meeting are now available. ...
Posted by Michael Wonder on 19 Sep 2016
Real-world evidence: a comparison of the Australian Herceptin Program and clinical trials of trastuzumab for HER2-positive metastatic breast cancer
19 September 2016 - Estimating the real-world cost-effectiveness of a new drug relies on understanding the differences between clinical trial data ...
Posted by Michael Wonder on 31 Aug 2016
Schedule of Pharmaceutical Benefits - 1 September 2016 update
1 September 2016 - The 1 September 2016 issue of the Schedule of Pharmaceutical Benefits sees a number of new ...